AbbVie Enters Obesity Field with Gubra’s GUB014295 Licensing Deal
US pharmaceutical giant AbbVie (NYSE: ABBV) announced that it is making significant progress in the...
Fineline Cube
Zeiss Group’s VISUMAX 800 with SMILE pro Software Approved by China’s NMPA
Germany-based Zeiss Group, a specialist in optical systems and optoelectronic product manufacturing, announced that it...
Laekna’s LAE120 Receives FDA Approval for Solid Tumor Clinical Trials
Sino-US biotech company Laekna, Inc. (HKG: 2105) announced that it has received clinical trial approval...
SynerK’s SNK-2726 Gets FDA Green Light for Phase I Hypertension Study
SynerK, an RNA-targeted therapy developer with operations in Boston, US, and Beijing and Suzhou, China,...
Omron Healthcare and China Jo-Jo Drugstores Launch Atrial Fibrillation Screening Zone
A joint effort between Japan-based Omron Healthcare and China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD), a...
WORK Medical and Chartwell Med Partner on Investment Tools for Healthcare Projects
WORK Medical Technology Group Ltd (NASDAQ: WOK), a medical consumables company based in Hangzhou, has...
Innovent Biologics Doses First Patient in IBI363 Melanoma Study vs Keytruda
China-based Innovent Biologics, Inc. (HKG: 1801) announced the first patient dosing in the pivotal regulatory...
Eyebright Medtech Plans Private Placement to Expand Contact Lens Production
China-based Eyebright Medical Technology (Beijing) Co., Ltd. (SHA: 688050), an ophthalmic medical device manufacturer, announced...
Sinocelltech’s Finotonlimab Gets NMPA Approval for Liver Cancer Treatment
China-based Sinocelltech Group Ltd (SHA: 688520) announced that it has received another indication approval from...
Danatlas Raises RMB 150M to Advance Synthetic Lethality Drug Pipeline
Beijing-headquartered Danatlas, a first-in-class drug developer in the synthetic lethality field, has reportedly raised RMB...
Magnet Biomedicine and Eli Lilly Partner on Molecular Glue Therapeutics
US-based molecular glue specialist Magnet Biomedicine has entered into a collaboration and license agreement with...
AstraZeneca and Amgen’s Tezspire Shows Positive Results in Phase III Study
AstraZeneca (NASDAQ: AZN) and Amgen (NASDAQ: AMGN) have jointly announced positive results from the Phase...
Baidu Health Partners with Jolly Pharma to Boost Digital Drug Marketing
Baidu Health, an internet giant, has entered into a partnership with Zhejiang Jolly Pharmaceutical Co.,...
Duality Biotherapeutics Updates IPO Filing with HKSE under Chapter 18A Rules
China-based Duality Biotherapeutics, Inc. updated its initial public offering (IPO) filing to the Hong Kong...
CARsgen’s CT041 Awarded Breakthrough Therapy Designation for Gastric Cancer
CARsgen Therapeutics Holdings Ltd (HKG: 2171) announced that its chimeric antigen receptor (CAR) T-cell therapy,...
Huge Dental Files for Hong Kong IPO with Diverse Dental Product Portfolio
Shandong-based dental materials company Huge Dental Limited has made an initial public offering (IPO) filing...
CSPC Pharmaceutical’s Sirolimus Receives BTD for Malignant PEComa Treatment
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) announced that it has received Breakthrough Therapy Designation...
Pulnovo Medical Raises USD 100M in Series C Financing for Global Expansion
Wuxi-based Pulnovo Medical Limited, a developer of medical devices for pulmonary hypertension and heart failure,...
Grand Pharma Sells Telix Shares for AUD 143M to Fund Clinical Programs
China-based Grand Pharmaceutical Group Co., Ltd. (HKG: 0512) announced the sale of 4,947,181 shares in...
AI in Healthcare: Accelerating Applications in Diagnostics and Multi-omics Analysis
The breakthrough technology of DeepSeek has significantly accelerated the application of AI in the medical...